Agios Pharma (AGIO) Tops Q1 EPS by 23c

Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.47), $0.23 better than the analyst estimate of ($1.70). Revenue for the quarter came in at $5.6 million versus the consensus estimate of $5.37 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Aspire Biopharma to acquire automotive supplier for $30 million
• Independent Bank receives regulatory approval for HCB Financial acquisition